2021 is coming to a close, and while we are optimistic for a return to a more traditional environment in 2022, we recognize the valuable shift we’ve seen to more virtual and hybrid industry events.
The recent 2021 PDA Aseptic Processing of Biopharmaceuticals Virtual Conference delivered engaging presentations, panel discussions, and case studies around cutting-edge topics. The event also provided many opportunities to gain access to top industry leaders, including regulatory representatives, and global vaccine experts.
Over the course of three days, the agenda covered compelling topics like the State of the Aseptic Manufacturing Process in the Times of Covid-19 and Regulatory Strategy and Covid-19 Vaccine Development, the highly anticipated keynote speech by Jerome Kim, Director General of the South Korea-based International Vaccine Institute. He emphasized that “approving a vaccine is only the first of many complicated steps to ensuring that everyone across the world has access to one or more doses.”
As Oliver’s first time at this conference—organized by Parenteral Drug Association Asia Pacific—we contributed to the demo session with a short presentation titled The Relationship Between Packaging Adhesives and Particulate Generation in Nested Syringe Tubs.
At present, conferences and trade shows in the Asia Pacific region are using more of the hybrid version, utilizing a multitude of technologies to ensure online interaction, in-person attendance, and visitor dialogues.
Asia is opening up slowly, but cautiously. It would be great to have this conference as an “in-person connection”; nevertheless, important insights and knowledge were shared virtually.
